欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号BE/V/0046/001
药品名称Tri-solfen
活性成分
    • bupivacaine hydrochloride 4.2 g/l
    • cetrimide 5.0 g/l
    • epinephrine tartrate 0.02 g/l
    • lidocaine hydrochloride 40.6 g/l
剂型Cutaneous solution
上市许可持有人Dechra Regulatory B.V. Handelsweg 25 Bladel Netherlands
参考成员国 - 产品名称Belgium (BE)
Tri-Solfen
互认成员国 - 产品名称
    • Denmark (DK)
      Tri-solfen
    • Spain (ES)
    • Germany (DE)
    • Austria (AT)
    • Slovenia (SI)
    • Portugal (PT)
    • Poland (PL)
    • Netherlands (NL)
    • Italy (IT)
    • Ireland (IE)
    • Croatia (HR)
许可日期2021/12/15
最近更新日期2021/12/17
药物ATC编码
    • QD04AB51 lidocaine, combinations
申请类型
  • TypeLevel1:food
  • TypeLevel2:Pharmaceutical
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase